Sudeep Pharma IPO 2025 – Investment Opportunity for Retail Investors

Sudeep Pharma Limited, a globally recognized pharmaceutical excipients manufacturer founded in 1989, is launching its long-awaited IPO on November 21, 2025. This ₹895 crore book build issue presents an exciting investment opportunity for first-time IPO investors and experienced traders alike. With the Sudeep Pharma IPO price band set at ₹563 to ₹593 per share, retail investors can participate with a minimum investment of just ₹14,825. In this comprehensive guide, we'll walk you through everything you need to know about this pharmaceutical IPO, including how to apply seamlessly through IPO Ji, India's leading IPO investment platform.

What is Sudeep Pharma IPO? | Company Overview & Business Profile

Sudeep Pharma Limited: Three Decades of Excellence in Pharma Excipients

Sudeep Pharma Limited is a USFDA-certified pharmaceutical manufacturer specializing in mineral-based pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. Incorporated in 1989 and headquartered in Vadodara, Gujarat, the company has established itself as a global leader serving over 100 countries with more than 200 innovative products.

The company operates six state-of-the-art manufacturing facilities with a combined production capacity of 50,000 MT annually, making it one of the largest producers of mineral-based ingredients in India. Sudeep Pharma supplies essential minerals including calcium, iron, magnesium, zinc, potassium, and sodium to the pharmaceutical, food, and nutrition industries. With 704 permanent employees and over 1,000 global customers, the company demonstrates strong market presence and operational excellence.

 Key Competitive Strengths of Sudeep Pharma

- Market Leadership: Industry-leading position in pharmaceutical excipients and mineral actives

- Global Presence: Trusted supplier to 100+ countries with established customer relationships

- World-Class Certifications: USFDA approval, WHO-GMP, FSSC 22000, EXCiPACT, ISO 9001:2015, Kosher, and Halal certifications

- Strong R&D Capabilities: In-house laboratories and pilot-scale facilities focused on innovation

- Diversified Product Portfolio: 200+ products across pharma, food, and nutrition sectors

- Regulatory Compliance: Full compliance with international standards and California Prop 65 regulations

Sudeep Pharma IPO Details | Complete Issue Information for November 2025

 IPO Specifications: Size, Price Band, and Subscription Timeline

Sudeep Pharma IPO: Fresh Issue vs. Offer for Sale Explained

This combination issue comprises two components:

1. Fresh Issue (₹95 Crore): New shares issued by the company to raise capital for business expansion and machinery procurement

2. Offer for Sale (₹800 Crore): Existing shares offered by promoters (Bhayani family) for partial exit

This structure allows retail investors to participate in both company growth (fresh issue) and provides liquidity to promoters, making it an attractive IPO for investors seeking exposure to a growing pharmaceutical company.

Sudeep Pharma IPO Investment Eligibility | Who Can Apply?

Minimum Investment Requirements by Investor Category

Sudeep Pharma IPO has allocated shares across three investor categories following SEBI guidelines for book-built IPOs:

 IPO Allocation Across Investor Categories (SEBI Norms)

- Retail Investors (RII): Minimum 35% of net offer reserved

- Non-Institutional Investors (NII): Minimum 15% of net offer reserved

- Qualified Institutional Buyers (QIBs): Maximum 50% of net offer available

 How to Apply for Sudeep Pharma IPO on IPO Ji | Step-by-Step Application Guide

 Why Choose IPO Ji for Sudeep Pharma IPO Application?

IPO Ji is India's most trusted and user-friendly IPO application platform, offering:

- Seamless UPI and ASBA-based application process

- Real-time updates on IPO status and allotment

- Transparent bid tracking and live subscription status

- Expert analysis and GMP (Grey Market Premium) tracking

- Dedicated customer support for first-time IPO investors

- Zero additional charges for IPO applications

 Method 1: Apply for Sudeep Pharma IPO Using UPI on IPO Ji

How to Apply for Sudeep Pharma IPO via UPI

1. Open the IPO Ji website/app and log in (or sign up using PAN, demat & bank details).
2. Go to Current IPOs and select Sudeep Pharma IPO.
3. Check the price band, lot size & dates, then click Apply Now.
4. Enter lots (1 lot = 25 shares = ₹14,825 at ₹593).
5. Choose UPI, enter your UPI ID, and submit.
6. Approve the UPI mandate in your UPI app.
7. Track your bid under My Bids / Application Status.

 Method 2: Apply for Sudeep Pharma IPO Using ASBA

For investors preferring net banking ASBA method:

Steps to Apply via ASBA (Net Banking):

1. Log in to your designated bank's net banking portal

2. Find the IPO application section

3. Choose this IPO from the available list

4. Enter Application Details:

   - Number of shares/lots

   - Bid price (within ₹563-₹593 range)

   - Demat account number

5. Confirm all entered information

6. The system will calculate the amount based on upper price

7. Accept all IPO-related terms

8. Complete the submission process

9. Receive application reference number via SMS/email

 Understanding Sudeep Pharma IPO Financial Performance | Key Metrics & Valuation

Financial Overview: Revenue, Profit, and Growth

Key Performance Indicators (KPIs) for Valuation Analysis

EPS Analysis: Pre-IPO vs. Post-IPO

Note: Post-IPO EPS is lower due to share dilution from new share issuance. However, the fresh capital will support capacity expansion and long-term growth.

Use of IPO Proceeds | How Sudeep Pharma Will Use ₹95 Crore Fresh Capital

Sudeep Pharma has clearly outlined its capital expenditure plans from the ₹95 crore fresh issue:

Strategic Significance: This capital will enable the company to increase production capacity, reduce per-unit costs, and capture greater market share in the growing pharmaceutical excipients sector.

Sudeep Pharma IPO: Promoter Holding Analysis | Ownership Structure

 Pre-IPO and Post-IPO Shareholding Pattern

Promoters of Sudeep Pharma Limited

The company is promoted by the Bhayani family, consisting of:

- Sujit Jaysukh Bhayani (Chairman & Managing Director)

- Avani Sujit Bhayani

- Shanil Sujit Bhayani

- Sujeet Jaysukh Bhayani HUF

- Riva Resources Private Limited (family company)

- Bhayani Family Trust

Sudeep Pharma IPO Timeline | Important Dates and Key Events

 Complete IPO Schedule (Tentative Dates)

Sudeep Pharma IPO Lead Managers and Registrar | Key Market Participants

Book Running Lead Managers (BRLMs)

The IPO is being managed by two reputed merchant banks:

1. ICICI Securities Limited

   - Lead Manager

   - Experience: Track record of successful IPO management

   - Role: Price discovery, investor engagement, underwriting

2. IIFL Capital Services Limited

   - Lead Manager

   - Experience: Strong presence in IPO market

   - Role: Investor relations, book building management

 IPO Registrar

MUFG Intime India Pvt. Ltd.

- Official IPO Registrar

- Handles: Application processing, allotment, and demat credit

- Contact: sudeeppharma.ipo@in.mpms.mufg.com

- Phone: +91-22-4918 6270

- Website: linkintime.co.in